Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts
article
OA: diamond
CC0
⤵ 4 in-corpus citations
Abstract
OBJECTIVE: To determine the clinical significance of serum follistatin levels in women with an ovarian endometrioma. MATERIALS AND METHODS: This is a prospective study of 89 women, 56 with an ovarian endometrioma (endometrioma group) and 33 with a benign ovarian cyst (control group) who underwent laparoscopic excision. Age, parity, body mass index, serum CA-125, serum CA 19-9, and serum follistatin levels were determined for all participants and evaluated as potential prognostic factors prior to laparoscopic cystectomy. RESULTS: There were no significant differences in demographic factors between the endometrioma group and the control group. However, serum follistatin levels were significantly higher in the endometrioma group (9350 ± 895 pg/mL vs. control group 725 ± 72 pg/mL, p < 0.05). The optimal diagnostic cut-off values (sensitivity and specificity) of CA-125, CA 19-9, and follistatin for ovarian endometrioma were 23.2 IU/mL (82.14% and 72.73%), 30.14 IU/mL (45.28% and 87.50%), and 2350 pg/mL (53.7% and 60.61%), respectively. CONCLUSION: Despite the increased serum follistatin levels in patients with ovarian endometrioma, CA-125 was determined to be a more sensitive and specific marker than follistatin for the diagnosis of ovarian endometrioma and endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Advances in the management of endometriosis: an update for clinicians via openalex
- Clinicopathologic risk factors for recurrence of ovarian endometrioma following laparoscopic cystectomy via openalex
- Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis via openalex
- Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- High serum follistatin levels in women with ovarian endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- W4211081176 via openalex
- W1983947024 via openalex
- W2022575728 via openalex
- W2031399745 via openalex
- W2087512818 via openalex
- W2108626419 via openalex
- W2125052189 via openalex
- W2135721067 via openalex
- W2283760758 via openalex
- W1974921074 via openalex
Cited by (4)
- Association between the level of TGF- β expression and endometriosis: A systematic review and meta-analysis 2024
- Directive clinique no 449 : Directive canadienne sur le diagnostic et les impacts de l’endométriose 2024
- Guideline No. 449: Diagnosis and Impact of Endometriosis – A Canadian Guideline 2024
- Ovarian Endometrioma and Infertility 2017
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:46.044120+00:00
License: CC0
· commercial use OK